# Pharmacokinetics of Y-4 Tablets With Pregabalin Capsules and Riluzole Tablets in Chinese Healthy Subject

> **NCT06935721** · PHASE1 · RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Healthy Male and Female Subjects

## Interventions

- **DRUG:** Y-4 tablet
- **DRUG:** Pregabalin capsule
- **DRUG:** Riluzole tablet

## Key facts

- **NCT ID:** NCT06935721
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-28
- **Primary completion:** 2025-05
- **Final completion:** 2025-06
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-04-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06935721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06935721, "Pharmacokinetics of Y-4 Tablets With Pregabalin Capsules and Riluzole Tablets in Chinese Healthy Subject". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT06935721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*